Clavulanate Potassium Powder
NDC Package 39390-0044-1
Package Information
Clavulanate Potassium powders is a bulk ingredient utilized for pharmaceutical compounding or manufacturing. This formulation utilizes a powder delivery system. Marketed by Fermic, S.a. De C.v., this product is identified by NDC 39390-0044.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 39390 - Fermic, S.a. De C.v.
- 39390-0044 -
- 39390-0044-1 - 25 kg in 1 DRUM
- 39390-0044 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 39390-0044-1 identifies a specific commercial package of 25 kg in 1 drum of Clavulanate Potassium (UNFINISHED drug), a bulk ingredient labeled by Fermic, S.a. De C.v.. This powder is formulated for use and contains clavulanate potassium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fermic, S.a. De C.v. on November 23, 2018.
How is this Fermic, S.a. De C.v. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 39390004401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.